# Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)

> **NCT07491380** · NA · NOT_YET_RECRUITING · sponsor: **Institut Curie** · enrollment: 90 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Capillary samples using the VAMS Mitra device

## Key facts

- **NCT ID:** NCT07491380
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2027-12-15
- **Final completion:** 2028-12-15
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07491380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07491380, "Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07491380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*